Literature DB >> 10863144

Temporal profile of CRE DNA-binding activity in the rat hippocampus following a kindling stimulation.

K Kashihara1, K Sato, K Akiyama, T Ishihara, T Hayabara, K Abe.   

Abstract

This study was designed to establish a role for cAMP-responsive element (CRE) binding protein (CREB) in signal transduction cascade in the hippocampus associated with kindling. Male Sprague-Dawley rats were kindled from the left amygdala until they exhibited Racine's class 5 generalized seizures [Racine (1972). EMBO J. 11, 3337-3346] Nuclear proteins were extracted from dorsal hippocampi obtained from 0 to 24 h after final kindling stimulation. From these, we evaluated the temporal pattern of CRE DNA-binding activity by use of a gel mobility-shift assay with a 32P-labeled CREB oligonucleotide probe. CRE-binding activity in the hippocampus was enhanced significantly at 2 h and returned to baseline level within 4 h after the stimulation. Our results suggest that CREB may be involved in the hippocampal signal transduction pathway of rats activated in response to a kindling stimulation to the amygdala. However, the transient elevation of CRE-binding activity following a seizure in a kindled animal also suggests that persistent activation of CREB may not be required for maintenance of the kindling phenomenon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863144     DOI: 10.1016/s0920-1211(00)00123-6

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  2 in total

1.  The role of transcription factors cyclic-AMP responsive element modulator (CREM) and inducible cyclic-AMP early repressor (ICER) in epileptogenesis.

Authors:  B E Porter; I V Lund; F P Varodayan; R W Wallace; J A Blendy
Journal:  Neuroscience       Date:  2008-01-17       Impact factor: 3.590

Review 2.  Inducible cAMP early repressor (ICER) and brain functions.

Authors:  Gilyana Borlikova; Shogo Endo
Journal:  Mol Neurobiol       Date:  2009-05-13       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.